IMPACT: This unique facility is actively developing vaccines to address serious illnesses in conjunction with corporate and government partners. It aims to benefit patients and create economic development.
Located adjacent to the Universities at Shady Grove along the I-270 bio-pharma corridor, the IBBR is thriving. A partnership involving UMB, UMCP, and the National Institute of Standards and Technology, it recently received a grant to develop and test therapies that could lead to a cure for HIV infections. IBBR also has a $6 million grant to develop a vaccine for hepatitis C and a new project with Leidos Biomedical Research, Inc., and the Frederick National Laboratory for Cancer Research to develop a new vaccine against HPV, a common cause of cervical cancer.
Institute for Bioscience and Biotechnology Research
- Categories: Research